Algernon Pharmaceuticals Inc (AGN.CX)
0.08
0.00 (0.00%)
CAD |
CNSX |
Nov 22, 12:21
Algernon Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 21, 2024 | 0.0343M |
November 20, 2024 | 0.0826M |
November 19, 2024 | 0.0343M |
November 18, 2024 | 0.0343M |
November 15, 2024 | 0.0343M |
November 14, 2024 | 0.0343M |
November 13, 2024 | 0.0826M |
November 12, 2024 | 0.0826M |
November 11, 2024 | 0.0826M |
November 08, 2024 | 0.1309M |
November 07, 2024 | 0.1309M |
November 06, 2024 | 0.1309M |
November 05, 2024 | 0.1309M |
November 04, 2024 | 0.1309M |
November 01, 2024 | 0.1309M |
October 31, 2024 | 0.0826M |
October 30, 2024 | 0.0826M |
October 29, 2024 | 0.0826M |
October 28, 2024 | 0.0826M |
October 25, 2024 | 0.1309M |
October 24, 2024 | 0.1309M |
October 23, 2024 | 0.1309M |
October 22, 2024 | 0.1791M |
October 21, 2024 | 0.1309M |
October 18, 2024 | 0.1309M |
Date | Value |
---|---|
October 17, 2024 | 0.1309M |
October 16, 2024 | 0.1309M |
October 15, 2024 | 0.0343M |
October 11, 2024 | 0.0826M |
October 10, 2024 | 0.0343M |
October 09, 2024 | 0.0826M |
October 08, 2024 | 0.1309M |
October 07, 2024 | 0.0826M |
October 04, 2024 | 0.1067M |
October 03, 2024 | 0.0826M |
October 02, 2024 | 0.0826M |
October 01, 2024 | 0.0826M |
September 30, 2024 | 0.1791M |
September 27, 2024 | 0.1791M |
September 26, 2024 | 0.1791M |
September 25, 2024 | 0.1309M |
September 24, 2024 | 0.1791M |
September 23, 2024 | 0.1791M |
September 20, 2024 | 0.1309M |
September 19, 2024 | 0.1791M |
September 18, 2024 | 0.1791M |
September 17, 2024 | 0.2274M |
September 16, 2024 | 0.2757M |
September 13, 2024 | 0.2274M |
September 12, 2024 | 0.2274M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.1105M
Minimum
Nov 15 2023
65.34M
Maximum
Dec 14 2020
11.21M
Average
5.596M
Median
Enterprise Value Benchmarks
Biocure Technology Inc | 0.4866M |
Core One Labs Inc | -- |
Restart Life Sciences Corp | 1.234M |
Nanosphere Health Sciences Inc | 0.2679M |
Lobe Sciences Ltd | 4.758M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.88M |
Total Expenses (Quarterly) | 1.880M |
EPS Diluted (Quarterly) | -0.1975 |